Real-time enrollment status for this hypercholesterolaemia clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:01 PM UTC
| NCT Number | NCT07610278 |
| Recruiting Status | Recruiting |
| Condition | Hypercholesterolaemia |
| Phase | PHASE2 |
| Target Enrollment | 120 participants |
| Active Locations | 29 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | July 30, 2026 (Jul 30, 2026) |
As of October 12, 2026: Clinical trial NCT07610278 is currently recruiting participants. This phase2 study for hypercholesterolaemia is actively seeking new participants at 29 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07610278 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 29 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07610278 was last updated Jul 30, 2026 (July 30, 2026). HelloStudys verifies this status automatically.